CTech's Thursday Roundup of Israeli Tech News
Former Reebok, Adidas execs partner with Israeli sports accelerator to launch $75 million sport tech fund; Venture firm New Era Capital raises a $60 million fund
15:5504.04.19
Former Reebok, Adidas execs partner with Israeli sports accelerator to launch $75 million sport tech fund. Uli Becker, former president of Reebok and Bernd Wahler, former chief marketing officer for Adidas and former president of German sports club VfB Stuttgart, have partnered with Israeli-born venture capitalist Amir Raveh to launch HYPE Capital. Read more
Soccer (illustration). Photo: Getty Images
Venture firm New Era Capital raises a $60 million fund. New Era focuses on startups touting a positive environmental and social impact. Read more
Virtual container startup Aqua Security raises $62 million. Aqua Security combines machine learning and threat research to offer an advanced security service for container-based and serverless applications. Read more
Israeli spacecraft Beresheet to perform lunar capture Thursday. Beresheet will attempt to slow down its speed as it leaves earth’s gravity to enter the moon’s orbit. Read more
JVP partners with Netafim to scout for agritech, foodtech startups in the Galilee. JVP Chairman Erel Margalit and Netafim CEO Ran Maidan announced the partnership at an event celebrating the construction of a new foodtech hub in Kiryat Shmona. Read more
Fintech startup Pagaya raises $25 million. Pagaya uses machine learning algorithms and big data analytics to manage institutional assets. Read more
Data science startup Run:AI raises $10 million. Run:AI develops software for automatically optimizing the use of computer resources for deep learning processes. Read more
Wide-area network startup Teridion raises $9 million. The Israel-based company develops a public, cloud-based wide-area network (WAN). Read more
Cybersecurity startup CyberHat raises $6 million. CyberHat offers security operations center services, including constant monitoring of a company’s security systems, as well as prediction, detection, and defense against hacks and other cyber threats. Read more
Can-Fite BioPharma to raise $3.2 million in direct offering. The NYSE and Tel Aviv-listed company develops small molecule drugs used in the treatment of liver and inflammatory diseases and cancer. Read more